Bibliographic Details
| Title: |
Actualización de las guías de manejo de la osteoporosis de la SEIOMM: abaloparatida. |
| Authors: |
Riancho, José A.1 rianchoj@unican.es, Millán, Marta Martín1, Peris, Pilar2, Martínez, Guillermo3 |
| Source: |
Journal of Osteoporosis & Mineral Metabolism / Revista de Osteoporosis y Metabolismo Mineral (Spanish edition). jul-sep2025, Vol. 17 Issue 3, p134-138. 5p. |
| Subjects: |
OSTEOPOROSIS, BONE density, BONE growth, PARATHYROID hormone, PROFESSIONAL standards, POSTMENOPAUSE, BONE fractures |
| Abstract (English): |
The article focuses on the update of the osteoporosis management guidelines from the Spanish Society for Bone and Mineral Research (SEIOMM), with a particular emphasis on the drug abaloparatide. It highlights that abaloparatide is a new bone-forming treatment that has demonstrated efficacy and safety comparable to teriparatide, being indicated for postmenopausal women at high risk of fracture. Additionally, the results of studies are presented that demonstrate its ability to increase bone mineral density and reduce the risk of fractures, as well as its most common adverse effects. The update of the guidelines aims to integrate this new drug into existing therapeutic algorithms. [Extracted from the article] |
| Abstract (Spanish): |
Introducción: la osteoporosis es un trastorno de elevada prevalencia. La SEIOMM publicó en 2022 unas guías de manejo de estos pacientes. La reciente comercialización en Europa de un nuevo fármaco, la abaloparatida, hace aconsejable considerar su papel dentro de las opciones terapéuticas. Objetivo y resultados: en este artículo se resume la información existente sobre la eficacia y la seguridad de la abaloparatida y se actualizan los algoritmos terapéuticos propuestos en la guía. Conclusión: la abaloparatida es un fármaco osteoformador con eficacia y seguridad similares a la teriparatida. Representa una nueva opción en el tratamiento de la osteoporosis grave con muy alto riesgo de fractura. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Osteoporosis & Mineral Metabolism / Revista de Osteoporosis y Metabolismo Mineral (Spanish edition) is the property of Ibanez y Plaza and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
MedicLatina |
